Literature DB >> 3309124

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.

C P Maury1, A M Teppo.   

Abstract

A sensitive radioimmunoassay was used for monitoring serum levels of endogenous cachectin/tumor necrosis factor alpha (TNF) in 10 renal transplant recipients. Acute allograft rejections were associated with marked elevations of circulating TNF. The peak levels of TNF (median 140 pg/ml) were in the same concentration range as previously reported in parasitic infections. The results show that the release of TNF into circulation is an early event in renal allograft rejection and that raised levels of TNF in man can also be induced by noninfectious stimuli.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3309124      PMCID: PMC2188737          DOI: 10.1084/jem.166.4.1132

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.

Authors:  D H Perlmutter; C A Dinarello; P I Punsal; H R Colten
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 2.  Tumour necrosis factor--an overview.

Authors:  C P Maury
Journal:  Acta Med Scand       Date:  1986

Review 3.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

4.  Monitoring of human renal allograft rejection with fine-needle aspiration cytology.

Authors:  P Häyry; E von Willebrand
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

5.  Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.

Authors:  J Kaye; S Gillis; S B Mizel; E M Shevach; T R Malek; C A Dinarello; L B Lachman; C A Janeway
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

6.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

7.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 8.  Interleukin 2: biology and biochemistry.

Authors:  S Gillis
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

9.  Raised serum levels of tumour necrosis factor in parasitic infections.

Authors:  P Scuderi; K E Sterling; K S Lam; P R Finley; K J Ryan; C G Ray; E Petersen; D J Slymen; S E Salmon
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Tumor necrosis factor-driven cell death in donor organ as a barrier to immunological tolerance.

Authors:  Rosalind L Ang; Adrian T Ting
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.

Authors:  Bulent Yildirim; Ramazan Sari; Nuran Isci
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

3.  Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomologous monkeys.

Authors:  H Ohzato; M Monden; K Yoshizaki; M Gotoh; T Kanai; K Umeshita; T Tono; N Nishimoto; T Kishimoto; T Mori
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

4.  Inhibitory effect of corticosteroids on the secretion of tumour necrosis factor (TNF) by monocytes is dependent on the stimulus inducing TNF synthesis.

Authors:  J M Debets; T J Ruers; M P van der Linden; C J van der Linden; W A Buurman
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 5.  Tumor necrosis factor: an update on basic research and clinical applications.

Authors:  M Schleuning; R Munker
Journal:  Klin Wochenschr       Date:  1990-09-03

6.  Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury.

Authors:  A Seekamp; J S Warren; D G Remick; G O Till; P A Ward
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Tumor necrosis factor-alpha mRNA expression in lipopolysaccharide-stimulated rat kidney. Chronological analysis of localization.

Authors:  E Noiri; S Kuwata; K Nosaka; K Tokunaga; T Juji; Y Shibata; K Kurokawa
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study.

Authors:  E Arbustini; M Grasso; M Diegoli; M Bramerio; A S Foglieni; M Albertario; L Martinelli; A Gavazzi; C Goggi; C Campana
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

9.  Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations.

Authors:  D G Remick; R M Strieter; M K Eskandari; D T Nguyen; M A Genord; C L Raiford; S L Kunkel
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

10.  The effect of IL-6 on the des-gamma-carboxy prothrombin synthesis in human hepatoma cells.

Authors:  M Ono; H Kohda; T Naraki; H Ohta; M Ohhira; C Sekiya; M Namiki
Journal:  Gastroenterol Jpn       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.